Boris Shore
President bij NORTHERN POTASH CO.
Actieve functies van Boris Shore
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NORTHERN POTASH CO. | President | - | - |
| Algemeen Directeur | - | - |
Loopbaan van Boris Shore
Eerdere bekende functies van Boris Shore
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IMMUNE PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Boris Shore
| Moscow University | Undergraduate Degree |
Statistieken
Internationaal
| Rusland | 3 |
| Verenigde Staten | 2 |
Operationeel
| Chief Executive Officer | 1 |
| President | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Process Industries | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NORTHERN POTASH CO. | Process Industries |
| Bedrijven in privébezit | 1 |
|---|---|
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
- Beurs
- Insiders
- Boris Shore
- Ervaring
